Core One Labs Inc. (CSE:COOL), (OTCQB:CLABF), (Frankfurt:LD6, WKN:A3CSSU) is pleased to announce it has entered into a Letter of Intent with Medelys Laboratories...
The article How Interdisciplinary Research Could Reveal Psychedelics’ Blind Spots was originally published on Microdose. Most psychedelic research is...
The article APA Issues Position Statement on Psychedelics was originally published on Microdose. This past July, America’s oldest medical association,...
Researchers are comparing near-death experiences (NDE) to psychedelics-imagined “death” experiences to learn more about both. The post Psychedelics...
BeiGene’s BTK inhibitor Brukinsa (zanubrutinib) has become the first drug in the class to be recommended for routine The post NICE says yes to BeiGene’s...
PITTSBURGH, Sept. 21, 2022 – Simple computer-based neurocognitive training—using positive words and pictures designed to boost self-worth—prolongs...
The article Small Pharma Completes Enrollment in Phase IIa DMT Trial was originally published on Microdose. Small Pharma has started the week with some...
A jump in research studies sparks increased educational programs. The post The Future Psychedelics Workforce is Getting Schooled Today appeared first on...
PharmaTher Holdings Ltd. (OTCQB: PHRRF | CSE: PHRM), a leader in specialty ketamine pharmaceuticals, today announced that the Phase 1/2 clinical Study...
Traditional psychedelics have shown great potential for treating issues like depression, anxiety, PTSD, and addiction. Psilocybin and MDMA will likely...